These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

73 related articles for article (PubMed ID: 16881075)

  • 1. Macroscopic properties of spontaneous mutations in slow-channel syndrome: correlation by domain and disease severity.
    Zayas R; Lasalde-Dominicci J; Gomez CM
    Synapse; 2006 Nov; 60(6):441-9. PubMed ID: 16881075
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Desensitization of mutant acetylcholine receptors in transgenic mice reduces the amplitude of neuromuscular synaptic currents.
    Bhattacharyya BJ; Day JW; Gundeck JE; Leonard S; Wollmann RL; Gomez CM
    Synapse; 1997 Dec; 27(4):367-77. PubMed ID: 9372559
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mechanism of verapamil action on wild-type and slow-channel mutant human muscle acetylcholine receptor.
    Moriconi C; Di Castro MA; Fucile S; Eusebi F; Grassi F
    J Neurochem; 2010 Aug; 114(4):1231-40. PubMed ID: 20533996
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Modulation of the Ca(2+) permeability of human endplate acetylcholine receptor-channel.
    Piccari V; Deflorio C; Bigi R; Grassi F; Fucile S
    Cell Calcium; 2011 Apr; 49(4):272-8. PubMed ID: 21470676
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Inositol-1,4,5-triphosphate receptors mediate activity-induced synaptic Ca2+ signals in muscle fibers and Ca2+ overload in slow-channel syndrome.
    Zayas R; Groshong JS; Gomez CM
    Cell Calcium; 2007 Apr; 41(4):343-52. PubMed ID: 16973214
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Molecular bases and therapeutic strategies in defective neuromuscular transmissions: lessons learned from a prototypical synapse].
    Ohno K; Ito M; Masuda A
    Nihon Shinkei Seishin Yakurigaku Zasshi; 2009 Aug; 29(4):145-51. PubMed ID: 19764481
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Active calcium accumulation underlies severe weakness in a panel of mice with slow-channel syndrome.
    Gomez CM; Maselli RA; Groshong J; Zayas R; Wollmann RL; Cens T; Charnet P
    J Neurosci; 2002 Aug; 22(15):6447-57. PubMed ID: 12151524
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Slow-channel transgenic mice: a model of postsynaptic organellar degeneration at the neuromuscular junction.
    Gomez CM; Maselli R; Gundeck JE; Chao M; Day JW; Tamamizu S; Lasalde JA; McNamee M; Wollmann RL
    J Neurosci; 1997 Jun; 17(11):4170-9. PubMed ID: 9151734
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A transgenic mouse model of the slow-channel syndrome.
    Gomez CM; Bhattacharyya BB; Charnet P; Day JW; Labarca C; Wollmann RL; Lambert EH
    Muscle Nerve; 1996 Jan; 19(1):79-87. PubMed ID: 8538674
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A beta-subunit mutation in the acetylcholine receptor channel gate causes severe slow-channel syndrome.
    Gomez CM; Maselli R; Gammack J; Lasalde J; Tamamizu S; Cornblath DR; Lehar M; McNamee M; Kuncl RW
    Ann Neurol; 1996 Jun; 39(6):712-23. PubMed ID: 8651643
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Focal caspase activation underlies the endplate myopathy in slow-channel syndrome.
    Vohra BP; Groshong JS; Maselli RA; Verity MA; Wollmann RL; Gomez CM
    Ann Neurol; 2004 Mar; 55(3):347-52. PubMed ID: 14991812
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Redundancy of Cav2.1 channel accessory subunits in transmitter release at the mouse neuromuscular junction.
    Kaja S; Todorov B; van de Ven RC; Ferrari MD; Frants RR; van den Maagdenberg AM; Plomp JJ
    Brain Res; 2007 Apr; 1143():92-101. PubMed ID: 17320843
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mutation of the acetylcholine receptor alpha subunit causes a slow-channel myasthenic syndrome by enhancing agonist binding affinity.
    Sine SM; Ohno K; Bouzat C; Auerbach A; Milone M; Pruitt JN; Engel AG
    Neuron; 1995 Jul; 15(1):229-39. PubMed ID: 7619526
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Silencing rapsyn in vivo decreases acetylcholine receptors and augments sodium channels and secondary postsynaptic membrane folding.
    Martínez-Martínez P; Phernambucq M; Steinbusch L; Schaeffer L; Berrih-Aknin S; Duimel H; Frederik P; Molenaar P; De Baets MH; Losen M
    Neurobiol Dis; 2009 Jul; 35(1):14-23. PubMed ID: 19344765
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Activation of apoptotic pathways at muscle fiber synapses is circumscribed and reversible in a slow-channel syndrome model.
    Vohra BP; Groshong JS; Zayas R; Wollmann RL; Gomez CM
    Neurobiol Dis; 2006 Aug; 23(2):462-70. PubMed ID: 16815027
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Functional analysis of human CNGA3 mutations associated with colour blindness suggests impaired surface expression of channel mutants A3(R427C) and A3(R563C).
    Koeppen K; Reuter P; Kohl S; Baumann B; Ladewig T; Wissinger B
    Eur J Neurosci; 2008 May; 27(9):2391-401. PubMed ID: 18445228
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mutation I136V alters electrophysiological properties of the Na(v)1.7 channel in a family with onset of erythromelalgia in the second decade.
    Cheng X; Dib-Hajj SD; Tyrrell L; Waxman SG
    Mol Pain; 2008 Jan; 4():1. PubMed ID: 18171466
    [TBL] [Abstract][Full Text] [Related]  

  • 18. New mutations in acetylcholine receptor subunit genes reveal heterogeneity in the slow-channel congenital myasthenic syndrome.
    Engel AG; Ohno K; Milone M; Wang HL; Nakano S; Bouzat C; Pruitt JN; Hutchinson DO; Brengman JM; Bren N; Sieb JP; Sine SM
    Hum Mol Genet; 1996 Sep; 5(9):1217-27. PubMed ID: 8872460
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The bestrophin mutation A243V, linked to adult-onset vitelliform macular dystrophy, impairs its chloride channel function.
    Yu K; Cui Y; Hartzell HC
    Invest Ophthalmol Vis Sci; 2006 Nov; 47(11):4956-61. PubMed ID: 17065513
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Generalized epilepsy with febrile seizures plus-associated sodium channel beta1 subunit mutations severely reduce beta subunit-mediated modulation of sodium channel function.
    Xu R; Thomas EA; Gazina EV; Richards KL; Quick M; Wallace RH; Harkin LA; Heron SE; Berkovic SF; Scheffer IE; Mulley JC; Petrou S
    Neuroscience; 2007 Aug; 148(1):164-74. PubMed ID: 17629415
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.